BGM
IMMX icon

Burkehill Global Management’s Immix Biopharma IMMX Stock Holding History

Burkehill Global Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61M Buy
544,118
+250,000
+85% +$2.32M 0.2% 69
2026
Q1 		$2.68M Hold
294,118
– – 0.13% 111
2025
Q4 		$1.54M Buy
+294,118
New +$1.21M 0.1% 131

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Burkehill Global Management's IMMX Position: Q2 2026 in Review

Burkehill Global Management increased its Immix Biopharma (IMMX) stake by 85% in Q2 2026, buying an estimated $2.32M and bringing the position to 544,118 shares worth $5.61M. The position accounts for 0.2% of the portfolio, ranked #69.

Burkehill Global Management first reported a position in IMMX in Q4 2025 and has held it in 3 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Burkehill Global Management held 544,118 shares of Immix Biopharma worth $5.61M as of Q2 2026.
  • Burkehill Global Management bought 250,000 Immix Biopharma shares in Q2 2026, an estimated $2.32M.
  • Immix Biopharma made up 0.2% of Burkehill Global Management's portfolio in Q2 2026, its #69 holding.
  • Burkehill Global Management first reported a position in Immix Biopharma in Q4 2025 and has held it in 3 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.